Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.28217
Abstract: Key Points Question What are the clinicopathological characteristics and prognoses of patients with hepatoid adenocarcinoma of the stomach (HAS), and what is an accurate and efficient method of predicting overall survival (OS) among these patients?… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Gastric Cancer"
DOI: 10.1007/s10120-019-00965-5
Abstract: ObjectivesHepatoid adenocarcinoma of the stomach (HAS) is characterized by histological resemblance to hepatocellular carcinoma and a poor prognosis. The aim of this study is to elucidate the clinicopathological and molecular characteristics of HAS.MethodsForty-two patients with… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Current problems in cancer"
DOI: 10.1016/j.currproblcancer.2018.12.007
Abstract: BACKGROUND Hepatoid adenocarcinoma arising from urological system is extremely rare, and the pathogenesis and therapeutic regimen have been poorly understood. CASE REPORT we report a unique case of ɑ-fetaprotein (AFP)-producing neoplasm of renal pelvis associated… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Clinical Pathology"
DOI: 10.1136/jclinpath-2017-204928
Abstract: Aims α-Fetoprotein (AFP)-producing gastric carcinoma (AFPGC) is one of the most aggressive GC subtypes. Frequent expression of human epidermal growth factor receptor 2 (HER2) has previously been reported in hepatoid adenocarcinoma (HAC), a major histological… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "International journal of surgical pathology"
DOI: 10.1177/10668969221142038
Abstract: Hepatoid adenocarcinoma of the stomach is a rare histologic subtype of gastric carcinoma. Morphologically, it shows hepatocyte-like features and the tumor cells can show the expression of alpha-fetoprotein (AFP) in the tumor cells as well… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v8.i6.1164
Abstract: BACKGROUND The aim of the present study was to examine the clinical characteristics of hepatoid adenocarcinoma of the stomach (HAS) and its diagnosis, treatment, and prognosis. CASE SUMMARY A retrospective analysis of 13 HAS cases… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cancer Management and Research"
DOI: 10.2147/cmar.s186416
Abstract: Purpose Gastric hepatoid adenocarcinoma is a rare subtype of primary gastric cancer and is a high-grade form of malignancy. However, the pathogenesis and molecular biology of gastric hepatoid adenocarcinoma remain poorly understood. The aim of… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2019.01360
Abstract: Hepatoid adenocarcinoma of lung (HAL) is a rare and aggressive tumor. The current study reported a new HAL case in the right lower lung with high serum α-fetoprotein (AFP) level in a 71-year-old male patient.… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1036763
Abstract: Objective To analyze the CT findings of hepatoid adenocarcinoma of the stomach (HAS) and improve the diagnosis accuracy of this condition. Methods The CT images of 22 pathologically confirmed HAS patients were analyzed retrospectively. We… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14163849
Abstract: Simple Summary Hepatoid adenocarcinoma of the stomach (HAS) is a subset of gastric cancer (GC) histologically characterized by hepatocellular carcinoma-like foci with or without alpha-fetoprotein secretion, which is easily misdiagnosed. Genomic alterations and potential targets… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12061447
Abstract: We present the 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) findings in a 57-year-old woman with post-menopausal bleeding diagnosed with hepatoid adenocarcinoma (HAC) with a primary tumour in the uterine corpus and a highly elevated… read more here.